Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for Left Ventricular Remodeling in Acute MI
NCT03156816Phase 2Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Jul 2018
- Primary completion
- Nov 2020
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ST elevation myocardial infarction (STEMI) comparing Colchicine with Placebo (2 arms). Primary endpoint: Infarct size as estimated by CMR at 5 days. Started Jul 2018; status: completed.
02
Drugs
colchicine
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT03156816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03156816.